BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND PIM1, PIM, 5292, ENSG00000137193, P11309 AND Prognosis
11 results:

  • 1. Kinase pim1 promotes prostate cancer cell growth via c-Myc-RPS7-driven ribosomal stress.
    Zhang C; Qie Y; Yang T; Wang L; Du E; Liu Y; Xu Y; Qiao B; Zhang Z
    Carcinogenesis; 2019 Mar; 40(1):52-60. PubMed ID: 30247545
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Natural Compound Myricetin Effectively Represses the Malignant Progression of prostate cancer by Inhibiting pim1 and Disrupting the pim1/CXCR4 Interaction.
    Ye C; Zhang C; Huang H; Yang B; Xiao G; Kong D; Tian Q; Song Q; Song Y; Tan H; Wang Y; Zhou T; Zi X; Sun Y
    Cell Physiol Biochem; 2018; 48(3):1230-1244. PubMed ID: 30045021
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. pim1: a promising target in patients with triple-negative breast cancer.
    Zhao W; Qiu R; Li P; Yang J
    Med Oncol; 2017 Aug; 34(8):142. PubMed ID: 28721678
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. pim-3 is a Critical Risk Factor in Development and prognosis of prostate cancer.
    Qu Y; Zhang C; Du E; Wang A; Yang Y; Guo J; Wang A; Zhang Z; Xu Y
    Med Sci Monit; 2016 Nov; 22():4254-4260. PubMed ID: 27826135
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A small-molecule inhibitor of pim kinases as a potential treatment for urothelial carcinomas.
    Foulks JM; Carpenter KJ; Luo B; Xu Y; Senina A; Nix R; Chan A; Clifford A; Wilkes M; Vollmer D; Brenning B; Merx S; Lai S; McCullar MV; Ho KK; Albertson DJ; Call LT; Bearss JJ; Tripp S; Liu T; Stephens BJ; Mollard A; Warner SL; Bearss DJ; Kanner SB
    Neoplasia; 2014 May; 16(5):403-12. PubMed ID: 24953177
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Stabilization of the prostate-specific tumor suppressor NKX3.1 by the oncogenic protein kinase pim-1 in prostate cancer cells.
    Padmanabhan A; Gosc EB; Bieberich CJ
    J Cell Biochem; 2013 May; 114(5):1050-7. PubMed ID: 23129228
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Expression of pim-1 in prostate cancer tissue and its relationship with PSA recurrence].
    Zhang CT; Xu Y; Luo F; Zhang ZH; Liu RL; Yang K; Ma BJ
    Zhonghua Nan Ke Xue; 2012 Apr; 18(4):323-6. PubMed ID: 22574367
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Using insights into pim1 structure to design new anticancer drugs.
    Schenone S; Tintori C; Botta M
    Curr Pharm Des; 2010; 16(35):3964-78. PubMed ID: 21158732
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Real-time quantitative RT-PCR assessment of pim-1 and hK2 mRNA expression in benign prostate hyperplasia and prostate cancer.
    He HC; Bi XC; Zheng ZW; Dai QS; Han ZD; Liang YX; Ye YK; Zeng GH; Zhu G; Zhong WD
    Med Oncol; 2009; 26(3):303-8. PubMed ID: 19003546
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Potential roles for the pim1 kinase in human cancer - a molecular and therapeutic appraisal.
    Shah N; Pang B; Yeoh KG; Thorn S; Chen CS; Lilly MB; Salto-Tellez M
    Eur J Cancer; 2008 Oct; 44(15):2144-51. PubMed ID: 18715779
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Hypoxia-inducible proto-oncogene pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma.
    Reiser-Erkan C; Erkan M; Pan Z; Bekasi S; Giese NA; Streit S; Michalski CW; Friess H; Kleeff J
    Cancer Biol Ther; 2008 Sep; 7(9):1352-9. PubMed ID: 18708761
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.